Does parathyroid hormone affect erythropoietin therapy in dialysis patients?

Nabieh, Al Hilali; Hani, Al Humoud; Vadakethu T., Ninan; Mangalathillam R.N., Nampoory; Mini A., Puliyclil; Kaivilayil V., Johny

Nabieh, Al Hilali; Hani, Al Humoud; Vadakethu T., Ninan; Mangalathillam R.N., Nampoory; Mini A., Puliyclil; Kaivilayil V., Johny.

Medical Principles and Practice. 2007; 16 (1): 63-67

in En | IMEMR | ID: emr-84447

Responsible library: EMRO

Subject(s)

Humans; Male; Female; Hyperparathyroidism; Anemia/drug therapy; Erythropoietin; Renal Dialysis; Peritoneal Dialysis, Continuous Ambulatory

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Erythropoietin / Renal Dialysis / Peritoneal Dialysis, Continuous Ambulatory / Hyperparathyroidism / Anemia Limits: Female / Humans / Male Language: En Journal: Med. Princ. Pract. Year: 2007

Search on Google

Add to My VHL

XML